we looked at clinical efficacy against mild, moderate &amp; severe covid-19, 7 days after 2nd dose. 20 cases we are seen: 6 vaccine group, 14 placebo â€“ vaccine efficacy 79.5%. primary efficacy endpoint met check_mark_button.